Compare SON & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SON | ALKS |
|---|---|---|
| Founded | 1899 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | 2050 |
| Industry | Containers/Packaging | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 6.1B |
| IPO Year | 2014 | 2012 |
| Metric | SON | ALKS |
|---|---|---|
| Price | $49.56 | $36.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 14 |
| Target Price | ★ $60.13 | $43.43 |
| AVG Volume (30 Days) | 1.3M | ★ 1.9M |
| Earning Date | 04-21-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.39% | N/A |
| EPS Growth | ★ 510.30 | N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $7,518,753,000.00 | $1,475,899,000.00 |
| Revenue This Year | $0.10 | $24.26 |
| Revenue Next Year | $1.82 | $4.47 |
| P/E Ratio | $71.64 | ★ N/A |
| Revenue Growth | ★ 41.72 | N/A |
| 52 Week Low | $38.65 | $25.17 |
| 52 Week High | $58.44 | $39.56 |
| Indicator | SON | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 46.93 | 58.04 |
| Support Level | $46.73 | $27.65 |
| Resistance Level | $52.71 | $39.56 |
| Average True Range (ATR) | 1.32 | 1.33 |
| MACD | -0.02 | -0.08 |
| Stochastic Oscillator | 52.57 | 49.36 |
Sonoco Products Co is engaged in the manufacture and supply of consumer and industrial packaging products, offering paper, metal, and plastic packaging solutions across multiple end markets. The company has two reportable segments: Consumer Packaging and Industrial Paper Packaging. The Consumer Packaging segment provides rigid packaging solutions mainly for food, beverage, household, personal care, and pharmaceutical products, while the Industrial Paper Packaging segment produces paper-based packaging materials such as tubes, cores, and protective packaging, supported by paper mills and recycling operations, serving industrial and consumer markets. It generates the majority of its revenue from the Consumer Packaging segment.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.